Dasa Zupancic

Prof. Dr. Dasa Zupancic

Institute of Cell Biology, Medical faculty, University of Ljubljana
orcid

Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
MWMichael Winder
Michael Winder
GTGunnar Tobin
Gunnar Tobin
Dasa ZupancicDasa Zupancic
Dasa Zupancic
RRRok Romih
Rok Romih
The urothelium was long considered to be a silent barrier protecting the body from the toxic effects of urine. However, today a number of dynamic abilities of the urothelium are well recognized, including its ability to act as a sensor of the intravesical environment. During recent years several pathways of these urothelial abilities have been proposed and a major part of these pathways includes release of signalling molecules. It is now evident that the urothelium represents only one part of the sensory web. Urinary bladder signalling is finely tuned machinery of signalling molecules, acting in autocrine and paracrine manner, and their receptors are specifically distributed among different types of cells in the urinary bladder. In the present review the current knowledge of the formation, release, and signalling effects of urothelial acetylcholine, ATP, adenosine, and nitric oxide in health and disease is discussed.

27 April 2014 in BioMed Research International
Verified
Journal Article
Open access
PDF file
ISIgor Sterle
Igor Sterle
Dasa ZupancicDasa Zupancic
Dasa Zupancic
RRRok Romih
Rok Romih
Terminal differentiation of urothelium is a prerequisite for blood-urine barrier formation and enables normal sensory function of the urinary bladder. In this study, urothelial differentiation of normal human urothelium and of low and high grade papillary urothelial carcinomas was correlated with the expression and localization of purinergic receptors (P2X3, and P2X5) and transient receptor potential vanilloid channels (TRPV1, and TRPV4). Western blotting and immunofluorescence of uroplakins together with scanning electron microscopy of urothelial apical surface demonstrated terminal differentiation of normal urothelium, partial differentiation of low grade carcinoma, and poor differentiation of high grade carcinoma. P2X3 was expressed in normal urothelium as well as in low grade carcinoma and in both cases immunolabeling was stronger in the superficial cells. P2X3 expression decreased in high grade carcinoma. P2X5 expression was detected in normal urothelium and in high grade carcinoma, while in low grade carcinoma its expression was diminished. The expression of TRPV1 decreased in low grade and even more in high grade carcinoma when compared with normal urothelium, while TRPV4 expression was unchanged in all samples. Our results suggest that sensory proteins P2X3 and TRPV1 are in correlation with urothelial differentiation, while P2X5 and TRPV4 have unique expression patterns.

Verified
Journal Article
Open access
PDF file
LTLarisa Tratnjek
Larisa Tratnjek
JJJera Jeruc
Jera Jeruc
RRRok Romih
Rok Romih
Dasa ZupancicDasa Zupancic
Dasa Zupancic
Bladder cancer (BC) is the tenth most common cancer worldwide with a high recurrence rate, morbidity and mortality. Therefore, chemoprevention and improved treatment of BC are of paramount importance. Epidemiological studies suggest that adequate vitamin A intake may be associated with reduced BC risk. In addition, retinoids, natural and synthetic derivatives of vitamin A, are intensively studied in cancer research due to their antioxidant properties and their ability to regulate cell growth, differentiation, and apoptosis. Findings from in vivo and in vitro models of BC show great potential for the use of retinoids in the chemoprevention and treatment of BC. However, translation to the clinical practice is limited. In this narrative review we discuss: (i) vitamin A and retinoid metabolism and retinoic acid signalling, (ii) the pathobiology of BC and the need for chemoprevention, (iii) the epidemiological evidence for the role of dietary vitamin A in BC, (iv) mechanistic insights obtained from in vivo and in vitro models, (v) clinical trials of retinoids and the limitations of retinoid use, (vi) novel systems of retinoid delivery, and (vii) components of retinoid signalling pathways as potential novel therapeutic targets.

5 July 2013 in Protoplasma
Verified
Journal Article
Closed access
PDF file
Dasa ZupancicDasa Zupancic
Dasa Zupancic
MKMateja Erdani Kreft
Mateja Erdani Kreft
RRRok Romih
Rok Romih

19 August 2011 in Histochemistry and Cell Biology
Verified
Journal Article
Closed access
PDF file
Dasa ZupancicDasa Zupancic
Dasa Zupancic
MZMaja Zakrajšek
Maja Zakrajšek
GZGe Zhou
Ge Zhou
RRRok Romih
Rok Romih

29 October 2007 in Journal of Pineal Research
Verified
Journal Article
Closed access
PDF file
Dasa ZupancicDasa Zupancic
Dasa Zupancic
KJKristijan Jezernik
Kristijan Jezernik
GVGaj Vidmar
Gaj Vidmar